Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Moxifloxacin intermediate offering significant cost reduction and scalable manufacturing capabilities for global pharmaceutical supply chains demanding high purity.
Patent CN120098055A details a mild synthesis route for Prazomicin Impurity A000160, offering high yield and supply chain stability for pharmaceutical intermediates manufacturing.
Discover a novel synthesis method for Ertapenem Sodium via Patent CN114105988B. Achieve >99% purity and <10ppm heavy metals with our scalable, cost-effective manufacturing process.
Patent CN109970795A details a novel iridium catalyst achieving 98% ee. Discover cost reduction in chiral ligand manufacturing and supply chain advantages.
Patent CN104177253B details a novel route for 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid. Offers cost reduction and scalable supply for pharmaceutical partners.
Patent CN100480224C details a cost-effective Raney-Ni catalyzed route for Nabumetone, offering high purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN118324597A introduces nanoporous copper-iron catalysis for high-yield nitro reduction. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Discover the novel preparation method for Metconazole intermediates via CN103664561A. Achieve higher purity and reduced toxicity for scalable agrochemical manufacturing.
Novel two-step synthesis of 2,6-diaminotoluene from 2-chloro-6-nitrotoluene. High purity, reduced waste, scalable industrial route for polyurethane and dye intermediates.
Novel continuous fixed-bed process for high-purity pentamethyl dipropylene triamine. Reduces cost and improves yield for polyurethane foam additives manufacturing.
Patent CN107286043A details a low-pollution catalytic route for high-purity dye and pharma intermediates, offering significant cost reduction and supply chain reliability.
Patent CN118791432A enables high-purity Rimegepant intermediate synthesis via low-loading catalyst. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102951980A reveals a novel iridium-catalyzed method for producing chiral amines, offering significant cost reduction in agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN103214344B reveals efficient alkyne conversion. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chemical refining method for Isepamicin avoids chromatography ensuring high purity and supply stability for pharmaceutical manufacturing partners.
Novel 9-step synthesis for deoxycholic acid intermediates. Reduces steps, increases yield to 31.5%. Ideal for pharmaceutical supply chains and cost reduction.
Novel synthesis method for Fmoc-a-methyl-L-glutamic acid offering high yield and industrial scalability for pharmaceutical intermediate supply chains globally.
Patent CN103145609A details a safe CTH method for 2,3-dichloropyridine. Eliminate high-pressure hydrogen risks and achieve scalable agrochemical intermediate manufacturing.
Patent CN116920837B reveals high-efficiency dehydrogenation catalyst for carbazole production ensuring high purity and supply stability.
Patent CN108083980B details a high-yield L-menthol process using chiral phosphine ligands, offering stable supply and cost reduction in flavors manufacturing.